In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
Larimar Therapeutics Inc (NASDAQ: LRMR) closed the day trading at $3.15 down -6.53% from the previous closing price of $3.37. In other words, the price has decreased by -$6.53 from its previous closing price. On the day, 0.51 million shares were traded. LRMR stock price reached its highest trading level at $3.31 during the session, while it also had its lowest trading level at $3.12.
Ratios:
For a better understanding of LRMR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.10 and its Current Ratio is at 13.10. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on January 29, 2025, initiated with a Buy rating and assigned the stock a target price of $18.
On October 16, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $26.
On October 03, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $22.Wedbush initiated its Outperform rating on October 03, 2024, with a $22 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 16 ’24 when Hamilton Thomas Edward bought 57,208 shares for $8.74 per share. The transaction valued at 499,998 led to the insider holds 564,798 shares of the business.
Flynn James E bought 4,290,617 shares of LRMR for $37,499,993 on Feb 16 ’24. The Director now owns 6,151,406 shares after completing the transaction at $8.74 per share. On Feb 14 ’24, another insider, THOMAS FRANK E, who serves as the Director of the company, bought 2,000 shares for $11.00 each. As a result, the insider paid 22,000 and bolstered with 2,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LRMR now has a Market Capitalization of 200990800 and an Enterprise Value of 2645878.
Stock Price History:
The Beta on a monthly basis for LRMR is 0.96, which has changed by -0.7182274 over the last 52 weeks, in comparison to a change of 0.21313763 over the same period for the S&P500. Over the past 52 weeks, LRMR has reached a high of $13.68, while it has fallen to a 52-week low of $3.01. The 50-Day Moving Average of the stock is -27.81%, while the 200-Day Moving Average is calculated to be -54.69%.
Shares Statistics:
Over the past 3-months, LRMR traded about 800.36K shares per day on average, while over the past 10 days, LRMR traded about 725120 shares per day. A total of 63.81M shares are outstanding, with a floating share count of 36.84M. Insiders hold about 42.27% of the company’s shares, while institutions hold 61.49% stake in the company. Shares short for LRMR as of 1738281600 were 5070734 with a Short Ratio of 6.55, compared to 1735603200 on 5070190. Therefore, it implies a Short% of Shares Outstanding of 5070734 and a Short% of Float of 12.1700004.
Earnings Estimates
Its stock is currently analyzed by 10.0 different market analysts. The consensus estimate for the next quarter is -$0.37, with high estimates of -$0.3 and low estimates of -$0.5.
Analysts are recommending an EPS of between -$1.11 and -$1.49 for the fiscal current year, implying an average EPS of -$1.22. EPS for the following year is -$1.66, with 9.0 analysts recommending between -$1.26 and -$2.2.
